Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
0.00
Cash
126.6M
Avg Qtr Burn
N/A
Short % of Float
0.05%
Insider Ownership
0.00%
Institutional Own.
2.69%
Qtr Updated
09/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PHAXIAM phages Details Staph aureus , Prosthetic joint infection | Phase 2 Data readout | |
PHAXIAM phages Details Endocarditis infections, Staph aureus | Phase 1 Update | |
Eryaspase (GRASPA) (asparaginase) Details Pancreatic cancer, Solid tumor/s, Cancer | Failed Discontinued | |
Eryaspase (GRASPA) (asparaginase) Details Leukemia, Acute lymphoblastic leukemia, Cancer | Failed Discontinued | |
Eryaspase (GRASPA) (asparaginase) Details Pancreatic cancer, Cancer | Failed Discontinued | |
Eryaspase (GRASPA) (asparaginase) Details Breast cancer, Triple-negative breast cancer , Cancer | Failed Discontinued |